HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome

Sci Transl Med. 2012 Feb 29;4(123):123ra25. doi: 10.1126/scitranslmed.3003165.

Abstract

Early immunological events during acute HIV infection are thought to fundamentally influence long-term disease outcome. Whereas the contribution of HIV-specific CD8 T cell responses to early viral control is well established, the role of HIV-specific CD4 T cell responses in the control of viral replication after acute infection is unknown. A growing body of evidence suggests that CD4 T cells-besides their helper function-have the capacity to directly recognize and kill virally infected cells. In a longitudinal study of a cohort of individuals acutely infected with HIV, we observed that subjects able to spontaneously control HIV replication in the absence of antiretroviral therapy showed a significant expansion of HIV-specific CD4 T cell responses-but not CD8 T cell responses-compared to subjects who progressed to a high viral set point (P = 0.038). Markedly, this expansion occurred before differences in viral load or CD4 T cell count and was characterized by robust cytolytic activity and expression of a distinct profile of perforin and granzymes at the earliest time point. Kaplan-Meier analysis revealed that the emergence of granzyme A(+) HIV-specific CD4 T cell responses at baseline was highly predictive of slower disease progression and clinical outcome (average days to CD4 T cell count <350/μl was 575 versus 306, P = 0.001). These data demonstrate that HIV-specific CD4 T cell responses can be used during the earliest phase of HIV infection as an immunological predictor of subsequent viral set point and disease outcome. Moreover, these data suggest that expansion of granzyme A(+) HIV-specific cytolytic CD4 T cell responses early during acute HIV infection contributes substantially to the control of viral replication.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Boston
  • CD4 Lymphocyte Count
  • CD4-Positive T-Lymphocytes / enzymology
  • CD4-Positive T-Lymphocytes / immunology*
  • CD4-Positive T-Lymphocytes / virology*
  • Cell Proliferation
  • Cells, Cultured
  • Coculture Techniques
  • Cytotoxicity, Immunologic
  • Disease Progression
  • Germany
  • Granzymes / metabolism
  • HIV Infections / diagnosis
  • HIV Infections / enzymology
  • HIV Infections / immunology*
  • HIV Infections / virology*
  • HIV-1 / genetics
  • HIV-1 / growth & development*
  • Humans
  • Kaplan-Meier Estimate
  • Longitudinal Studies
  • Lymphocyte Activation
  • Macrophages / immunology
  • Macrophages / virology
  • Phenotype
  • Prognosis
  • RNA, Viral / blood
  • Time Factors
  • Viral Load
  • Virus Replication

Substances

  • Biomarkers
  • RNA, Viral
  • Granzymes
  • GZMA protein, human